Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CorMedix Inc. Director's Dealing 2012

Sep 28, 2012

32333_dirs_2012-09-28_a02b09fa-767a-49c7-8138-80095d55865b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-09-20

Reporting Person: Lefkowitz Steven W (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Senior Convertible Note (convertible into common stock) $ n/a () 0 Direct
Warrant (right to purchase common stock) $ n/a () 0 Direct

Footnotes

F1: On September 24, 2012, the reporting person mistakenly reported on a Form 4 (the "Form 4") the purchase of $15,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share (the "Notes"); and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share (the "Warrant"). The reporting person deposited $15,000 in escrow for such purchase, which will remain in escrow until the final closing, if any, as determined by the Company. The disclosure in the Form 4 regarding the purchase of $35,000 of the Notes and the Warrant by the reporting person, indirectly through Wade Capital Corporation, is accurate.